NCT02487446 - Efficacy and Safety Study of QVA149 in COPD Patients | Biotech Hunter

Enrollment

357

Participants

Timeline

Start Date

July 28, 2015

Primary Completion Date

September 12, 2016

Study Completion Date

September 12, 2016

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG

QVA149

QVA149 capsules for inhalation, delivered via QVA149 single dose dry powder inhaler (SDDPI)

DRUG

Umeclidinium/vilanterol

Umeclidinium/vilanterol for inhalation, delivered via ELLIPTA® inhaler

DRUG

Placebo (umeclidinium/vilanterol)

Matching Placebo to umeclidinium/vilanterol for inhalation, delivered via ELLIPTA® inhaler

DRUG

Placebo (QVA149)

Matching Placebo to QVA149 capsules for inhalation, delivered via QVA149 SDDPI

Trial Locations (58)

10016

Novartis Investigative Site, New York

16684

Novartis Investigative Site, Tipton

19142

Novartis Investigative Site, Philadelphia

21044

Novartis Investigative Site, Columbia

23606

Novartis Investigative Site, Newport News

27103

Novartis Investigative Site, Winston-Salem

27262

Novartis Investigative Site, High Point

28031

Novartis Investigative Site, Cornelius

28054

Novartis Investigative Site, Gastonia

28078

Novartis Investigative Site, Huntersville

28207

Novartis Investigative Site, Charlotte

28602

Novartis Investigative Site, Hickory

30094

Novartis Investigative Site, Conyers

30096

Novartis Investigative Site, Duluth

32127

Novartis Investigative Site, Port Orange

32503

Novartis Investigative Site, Pensacola

32504

Novartis Investigative Site, Pensacola

32701

Novartis Investigative Site, Altamonte Springs

32720

Novartis Investigative Site, DeLand

33172

Novartis Investigative Site, Miami

34741

Novartis Investigative Site, Kissimmee

35501

Novartis Investigative Site, Jasper

36305

Novartis Investigative Site, Andalusia

43016

Novartis Investigative Site, Dublin

43213

Novartis Investigative Site, Columbus

43215

Novartis Investigative Site, Columbus

43302

Novartis Investigative Site, Marion

45242

Novartis Investigative Site, Cincinnati

55402

Novartis Investigative Site, Minneapolis

55407

Novartis Investigative Site, Minneapolis

55432

Novartis Investigative Site, Fridley

55435

Novartis Investigative Site, Edina

55441

Novartis Investigative Site, Plymouth

70119

Novartis Investigative Site, New Orleans

70458

Novartis Investigative Site, Slidell

70584

Novartis Investigative Site, Sunset

72703

Novartis Investigative Site, Fayetteville

75010

Novartis Investigative Site, Carrollton

75069

Novartis Investigative Site, McKinney

76109

Novartis Investigative Site, Fort Worth

76550

Novartis Investigative Site, Lampasas

77530

Novartis Investigative Site, Channelview

78130

Novartis Investigative Site, New Braunfels

80907

Novartis Investigative Site, Colorado Springs

83642

Novartis Investigative Site, Meridian

84102

Novartis Investigative Site, Salt Lake City

85283

Novartis Investigative Site, Tempe

85723

Novartis Investigative Site, Tucson

89014

Novartis Investigative Site, Henderson

92270

Novartis Investigative Site, Rancho Mirage

92647

Novartis Investigative Site, Huntington Beach

97213

Novartis Investigative Site, Portland

97504

Novartis Investigative Site, Medford

98405

Novartis Investigative Site, Tacoma

36207-5710

Novartis Investigative Site, Anniston

Unknown

Novartis Investigative Site, Multiple Locations

33316-192

Novartis Investigative Site, Fort Lauderdale